Roivant Sciences (ROIV) Earnings Date, Estimates & Call Transcripts $11.68 +0.13 (+1.13%) (As of 11/1/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Roivant Sciences Latest Earnings SummaryUpcoming Q2 Earnings DateNov. 12Before Market OpensConfirmedActual EPS (Aug. 8) $0.12 Beat By $0.33 Consensus EPS (Aug. 8) -$0.21 Roivant Sciences issued Q1 2025 earnings on August 8, 2024, reporting an EPS of $0.12, which topped analysts' consensus estimates of -$0.21 by $0.33. Quarterly revenue rose 155.1% year-over-year to $55.10 million, above analyst estimates of $30.72 million. With a trailing EPS of $5.56 and a P/E Ratio of 2.10, Roivant Sciences' earnings are expected to decrease next year, from ($1.14) to ($1.25) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckROIV Upcoming EarningsRoivant Sciences' next earnings date is scheduled for Tuesday, November 12, 2024, with a conference call scheduled for at 8:00 AM ET. Interested parties can register for or listen to the call. Get Roivant Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Roivant Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataROIV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ROIV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "The Great Cash Out." And it means YOUR so-called "safe stocks"could get cut in half.Today, you'll discover the sobering truth. Roivant Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.33-$0.33-$0.33Q2 20241-$0.33-$0.33-$0.33Q3 20241-$0.33-$0.33-$0.33Q4 20243-$0.39-$0.20-$0.31FY 20246-$1.38-$1.19-$1.30Q1 20252-$0.25-$0.23-$0.24Q2 20252-$0.33-$0.25-$0.29Q3 20252-$0.32-$0.25-$0.29Q4 20252-$0.26-$0.26-$0.26FY 20258-$1.16-$0.99-$1.08Q1 20261-$0.33-$0.33-$0.33Q2 20261-$0.33-$0.33-$0.33Q3 20261-$0.30-$0.30-$0.30Q4 20261-$0.30-$0.30-$0.30FY 20264($1.26)($1.26)($1.26) Roivant Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Confirmed)------- 8/8/2024Q1 2025-$0.21$0.12+$0.33-$0.60$30.72M$55.10M 5/30/2024Q4 2024-$0.31-$0.28+$0.03-$0.37$32.46M$28.93M 2/13/2024Q3 2024-$0.33-$0.26+$0.07-$6.55$30.72M$37.14M 11/13/2023Q2 2024-$0.35-$0.33+$0.02-$0.26$26.68M$37.10M 8/14/2023Q2 2023-$0.28-$0.38 -$0.10-$0.38$24.49M$21.60M 6/28/2023Q4 2023-$0.41-$0.20+$0.21-$0.35$18.94M$27.38M Get the Latest News and Ratings for ROIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/13/2023Q3 2023-$0.36-$0.49 -$0.13-$0.49$14.29M$17.05M 11/14/2022Q2 2023-$0.41-$0.42 -$0.01-$0.42$6.71M$12.53M Roivant Sciences Earnings - Frequently Asked Questions When is Roivant Sciences's earnings date? Roivant Sciences has confirmed that its next quarterly earnings data will be published on Tuesday, November 12th, 2024. Learn more on ROIV's earnings history. Did Roivant Sciences beat their earnings estimates last quarter? In the previous quarter, Roivant Sciences (NASDAQ:ROIV) reported $0.12 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.33. Learn more on analysts' earnings estimate vs. ROIV's actual earnings. How can I listen to Roivant Sciences's earnings conference call? The conference call for Roivant Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Roivant Sciences's conference call transcript? The conference call transcript for Roivant Sciences's latest earnings report can be read online. Read Transcript How much revenue does Roivant Sciences generate each year? Roivant Sciences (NASDAQ:ROIV) has a recorded annual revenue of $124.79 million. How much profit does Roivant Sciences generate each year? Roivant Sciences (NASDAQ:ROIV) has a recorded net income of $4.35 billion. ROIV has generated $5.56 earnings per share over the last four quarters. What is Roivant Sciences's price-to-earnings ratio? Roivant Sciences (NASDAQ:ROIV) has a trailing price-to-earnings ratio of 2.10. What is Roivant Sciences's EPS forecast for next year? Roivant Sciences's earnings are expected to decrease from ($1.14) per share to ($1.25) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies BioNTech Earnings BeiGene Earnings Teva Pharmaceutical Industries Earnings Ginkgo Bioworks Earnings Moderna Earnings Genmab A/S Earnings Summit Therapeutics Earnings Viatris Earnings Dr. Reddy's Laboratories Earnings Vaxcyte Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer Spending The Death Knell for U.S. Stocks (Ad)They are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "The Great Cash Out." And it means YOUR so-called "safe stocks"could get cut in half.Today, you'll discover the sobering truth. This page (NASDAQ:ROIV) was last updated on 11/3/2024 by MarketBeat.com Staff From Our PartnersThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | SponsoredAmerica dodged a crisis — next time it could be much worseLegendary financial forecaster, Dr. Martin Weiss, has been warning us about it for months … He believes the...Weiss Ratings | SponsoredCharles Payne Wants You Prepared for Q4Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market vola...Unstoppable Prosperity | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.